NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

Small "tweaks" in the process that provide NWBO with patent protection have made L different from UCLA's DC version. Now, you can ask if over time UCLA has slowly come to rely on NWBO/Advent for DCVAX-L instead of producing it on their own for their clinical trials, but you can't just say the two are the same without a real explanation from the company.